BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 9892010)

  • 1. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
    Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
    Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2.
    Florio T; Thellung S; Arena S; Corsaro A; Bajetto A; Schettini G; Stork PJ
    J Physiol Paris; 2000; 94(3-4):239-50. PubMed ID: 11088001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.
    Lahlou H; Saint-Laurent N; Estève JP; Eychène A; Pradayrol L; Pyronnet S; Susini C
    J Biol Chem; 2003 Oct; 278(41):39356-71. PubMed ID: 12878607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-intensity p38 kinase activity is critical for p21(cip1) induction and the antiproliferative function of G(i) protein-coupled receptors.
    Alderton F; Humphrey PP; Sellers LA
    Mol Pharmacol; 2001 May; 59(5):1119-28. PubMed ID: 11306695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated G protein-coupled receptor induces tyrosine phosphorylation of STAT3 and agonist-selective serine phosphorylation via sustained stimulation of mitogen-activated protein kinase. Resultant effects on cell proliferation.
    Sellers LA; Feniuk W; Humphrey PP; Lauder H
    J Biol Chem; 1999 Jun; 274(23):16423-30. PubMed ID: 10347203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
    Sharma K; Patel YC; Srikant CB
    Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta.
    Arena S; Pattarozzi A; Massa A; Esteve JP; Iuliano R; Fusco A; Susini C; Florio T
    Mol Endocrinol; 2007 Jan; 21(1):229-46. PubMed ID: 17021051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells.
    Florio T; Rim C; Hershberger RE; Loda M; Stork PJ
    Mol Endocrinol; 1994 Oct; 8(10):1289-97. PubMed ID: 7854346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
    Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein-tyrosine phosphatase SHP-2 is required during angiotensin II-mediated activation of cyclin D1 promoter in CHO-AT1A cells.
    Guillemot L; Levy A; Zhao ZJ; Bereziat G; Rothhut B
    J Biol Chem; 2000 Aug; 275(34):26349-58. PubMed ID: 10843991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.
    Bedecs K; Elbaz N; Sutren M; Masson M; Susini C; Strosberg AD; Nahmias C
    Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):449-54. PubMed ID: 9230127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras-dependent activation of fibroblast mitogen-activated protein kinase by 5-HT1A receptor via a G protein beta gamma-subunit-initiated pathway.
    Garnovskaya MN; van Biesen T; Hawe B; Casañas Ramos S; Lefkowitz RJ; Raymond JR
    Biochemistry; 1996 Oct; 35(43):13716-22. PubMed ID: 8901512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid-induced association of SHP-2 with SHPS-1: roles of RHO, FAK, and a SRC family kinase.
    Takeda H; Matozaki T; Fujioka Y; Takada T; Noguchi T; Yamao T; Tsuda M; Ochi F; Fukunaga K; Narumiya S; Yamamoto T; Kasuga M
    Oncogene; 1998 Jun; 16(23):3019-27. PubMed ID: 9662335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness.
    Reardon DB; Dent P; Wood SL; Kong T; Sturgill TW
    Mol Endocrinol; 1997 Jul; 11(8):1062-9. PubMed ID: 9212054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of extracellular-signal regulated kinase and c-Jun N-terminal kinase by G-protein-linked muscarinic acetylcholine receptors.
    Wylie PG; Challiss RA; Blank JL
    Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):619-28. PubMed ID: 10051431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1.
    Pagès P; Benali N; Saint-Laurent N; Estève JP; Schally AV; Tkaczuk J; Vaysse N; Susini C; Buscail L
    J Biol Chem; 1999 May; 274(21):15186-93. PubMed ID: 10329727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
    Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J
    Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases.
    Shi ZQ; Lu W; Feng GS
    J Biol Chem; 1998 Feb; 273(9):4904-8. PubMed ID: 9478933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
    J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.